{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:02:46Z","timestamp":1768878166293,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jceh.2014.05.003","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T15:17:41Z","timestamp":1403623061000},"page":"221-225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Role of Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis\u2014An Observational Study"],"prefix":"10.1016","volume":"4","author":[{"given":"Dinesh","family":"Jothimani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew E.","family":"Cramp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim J.S.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2014.05.003_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.05.003_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.05.003_bib3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its\u00a0efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.05.003_bib4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2014.05.003_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.mcg.0000139050.67178.be","article-title":"Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis","volume":"38","author":"Aqel","year":"2004","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2014.05.003_bib6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1010683817344","article-title":"Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis","volume":"46","author":"Malekzadeh","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2014.05.003_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1440-1746.2010.06579.x","article-title":"Treatment of autoimmune hepatitis: a review of current and evolving therapies","volume":"26","author":"Jothimani","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2014.05.003_bib8","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2036.2010.04241.x","article-title":"Review article: the modern management of autoimmune hepatitis","volume":"31","author":"Yeoman","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2014.05.003_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/TP.0b013e31822d880d","article-title":"Mycophenolate mofetil monotherapy in liver transplantation: 5-year follow-up of a prospective randomized trial","volume":"92","author":"Schmeding","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.05.003_bib10","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1097\/01.tp.0000187133.53916.8f","article-title":"Indications of mycophenolate mofetil in liver transplantation","volume":"80","author":"Klupp","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2014.05.003_bib11","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.transproceed.2005.06.073","article-title":"Use of mycophenolate mofetil in liver transplantation: a literature review","volume":"37","author":"Manzia","year":"2005","journal-title":"Transpl Proc"},{"key":"10.1016\/j.jceh.2014.05.003_bib12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","article-title":"A\u00a0single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis","volume":"6","author":"Hlivko","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2014.05.003_bib13","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.05.003_bib14","first-page":"690","article-title":"Chronic hepatitis: morphology and nomenclature","volume":"7","author":"Ishak","year":"1994","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jceh.2014.05.003_bib15","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1136\/gut.2010.235259","article-title":"British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis","volume":"60","author":"Gleeson","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2014.05.003_bib16","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jhep.2009.10.004","article-title":"Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitis","volume":"52","author":"Hindorf","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.05.003_bib17","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/01.mcg.0000177260.72692.e8","article-title":"Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease","volume":"39","author":"Czaja","year":"2005","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.jceh.2014.05.003_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0168-8278(00)80271-8","article-title":"Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine","volume":"33","author":"Richardson","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.05.003_bib19","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cgh.2007.02.030","article-title":"Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy","volume":"5","author":"Inductivo-Yu","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2014.05.003_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1155\/2004\/504591","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy","volume":"18","author":"Devlin","year":"2004","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.jceh.2014.05.003_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.humpath.2003.10.017","article-title":"Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis","volume":"35","author":"Brunt","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jceh.2014.05.003_bib22","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s10620-008-0632-0","article-title":"Mycophenolate mofetil for autoimmune hepatitis: a single practice experience","volume":"54","author":"Wolf","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2014.05.003_bib23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1478-3231.2005.01107.x","article-title":"Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus","volume":"25","author":"Chatur","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2014.05.003_bib24","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314002990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314002990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:02:39Z","timestamp":1760853759000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688314002990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0973688314002990"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2014.05.003","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Mycophenolate Mofetil for the Treatment of Autoimmune Hepatitis\u2014An Observational Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2014.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 INASL. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}